D-0510-2022 Class II Terminated

Recalled by Ultra Seal Corporation — New Paltz, NY

FDA drug recall D-0510-2022 was initiated by Ultra Seal Corporation on Jan 24, 2022 and is designated Class II. Reason for recall: cGMP deviations The recall status is terminated (terminated Oct 16, 2023). Affected quantity: 225,000 packets.

Recall Details

Product Type
Drugs
Report Date
Feb 9, 2022
Initiation Date
Jan 24, 2022
Termination Date
Oct 16, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
225,000 packets

Product Description

CETAFEN COUGH & COLD COUGH & COLD RELIEF (Acetaminophen 325 mg, Dextromethorphan HBr 15mg, Guaifenesin 200mg, phenylephrine HCl 5mg) Coated tablets, 2-count packets, Manufactured for: HARTHealth Seattle, WA 98124

Reason for Recall

cGMP deviations

Distribution Pattern

Nationwide within the United States

Code Information

Lot #: AK9841, Ex. Date 10/2022

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0510-2022
openFDA file date
Oct 26, 2026
Loaded by RegDataLab
Oct 27, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.